Propiedad y actividad de insiders de Caribou Biosciences, Inc. (CRBU): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.25 |
| Capitalización | $124M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-02-25 | Kelly Timothy P | S-Sale | 6,228 | $12K |
| 2026-02-20 | Kelly Timothy P | A-Award | 202,500 | $364K |
| 2026-02-20 | Kelly Timothy P | A-Award | 45,000 | |
| 2026-02-24 | Kelly Timothy P | S-Sale | 3,147 | $6K |
| 2026-02-20 | MCCLUNG BARBARA G | A-Award | 45,000 | |
| 2026-02-24 | MCCLUNG BARBARA G | S-Sale | 6,938 | $14K |
| 2026-02-20 | MCCLUNG BARBARA G | A-Award | 202,500 | $364K |
| 2026-02-20 | Khan Ruhi Ahmad | A-Award | 202,500 | $364K |
| 2026-02-20 | Khan Ruhi Ahmad | A-Award | 45,000 | |
| 2026-02-24 | Khan Ruhi Ahmad | S-Sale | 6,938 | $14K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $41.1M | $16.0M | $240.4M | $58.3M | $51.2M | $16.3M | $12.4M |
| Inversiones a Corto | $8.4M | 0 | $135.4M | $189.3M | $277.7M | $193.2M | $127.0M |
| Cuentas por Cobrar | $4.0M | $5.2M | $8.1M | $4.7M | $3.9M | $3.3M | $3.0M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $57.0M | $24.3M | $391.2M | $260.2M | $338.8M | $219.4M | $145.2M |
| Inmovilizado Material | $4.3M | $3.5M | $4.9M | $34.9M | $40.5M | $39.3M | $24.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $61.9M | $36.0M | $442.4M | $373.8M | $432.2M | $313.3M | $175.4M |
| Cuentas por Pagar | $2.5M | $2.6M | $4.0M | $1.1M | $3.1M | $2.5M | $5.8M |
| Deuda a Corto | $532000 | $654000 | $259000 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $10.1M | $12.4M | $25.8M | $28.1M | $28.3M | $30.7M | $25.4M |
| Deuda a Largo | 0 | $924000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $54.5M | $59.5M | $54.5M | $72.9M | $63.8M | $60.4M | $53.2M |
| Reservas | $3.4M | -$30.9M | -$97.8M | -$197.2M | -$299.3M | -$448.4M | -$596.5M |
| Patrimonio Neto | $7.5M | -$23.4M | $387.8M | $300.9M | $368.4M | $253.0M | $122.2M |
| Deuda Total | $532000 | $1.6M | $259000 | $27.7M | $27.1M | $26.5M | $27.2M |
| Deuda Neta | -$48.9M | -$14.4M | -$375.6M | -$219.9M | -$301.7M | -$183.1M | -$112.1M |
| Capital Circulante | $46.9M | $11.9M | $365.4M | $232.1M | $310.5M | $188.7M | $119.8M |
Salud financiera
| Deuda / Patrimonio | 0.27 |
| Ratio corriente | 6.49 |
Rentabilidad
| Rentabilidad sobre capital | -89.11% |
| Rentabilidad sobre capital invertido | -86.30% |
| Rentabilidad sobre activos | -72.42% |
| Margen bruto | -129.70% |
| Margen operativo | -1090.90% |
| Margen neto | -1030.42% |
Empresas relacionadas: AARD · ALLO · ENTA · FHTX · HUMA · IVA · OBIO
Explorar sector: Healthcare · Biotechnology
Más secciones de CRBU: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones